Eisai
4523.T
$44.26
Share price
0.95%
Change (1 day)
-26.91%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Earnings for Eisai (4523.T)
Earnings in 2024 (TTM): A$0.66 Billion
According to Eisai's latest financial reports the company's current earnings are A$5.06 Billion. In 2023 the company made an earning of A$0.86 Billion, an increase over its 2022 earnings that were of -A$37.81 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eisai from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | A$0.66 B | -23.41% |
| 2023 | A$0.86 B | -2392.87% |
| 2022 | -A$37.81 Million | -103.6% |
| 2021 | A$1.05 B | -39.52% |
| 2020 | A$1.73 B | 7.3% |
| 2019 | A$1.61 B | 17.23% |
| 2018 | A$1.38 B | 86.06% |
| 2017 | A$0.74 B | -23.64% |
| 2016 | A$0.97 B | 27.28% |
| 2015 | A$0.76 B | 22.08% |
| 2014 | A$0.62 B | -46.11% |
| 2013 | A$1.16 B | -21.67% |
| 2012 | A$1.48 B | -20.72% |
| 2011 | A$1.86 B | -8.44% |
| 2010 | A$2.04 B | 18.85% |
| 2009 | A$1.71 B |